Core Viewpoint - TE Healthcare (06877) anticipates a comprehensive loss attributable to shareholders of approximately HKD 7.1 million for the year ending December 31, 2025, following a projected comprehensive profit of approximately HKD 11.3 million for the year ending December 31, 2024 [1] Financial Performance - For the year ending December 31, 2025, the company expects to achieve other income of approximately HKD 4.6 million, a decrease of about 71% compared to other income of approximately HKD 16.3 million for the year ending December 31, 2024 [1] - The overall profitability of the company is negatively impacted by significant increases in administrative and operational expenses due to the expansion of B2C sales channels and digital marketing activities [1] Business Development - The company continues to expand its healthcare business and achieve growth in its B2C operations [1] - The anticipated loss for the year ending December 31, 2025, is also attributed to high professional and legal fees arising from specific corporate transactions and ongoing litigation matters [1]
TE HEALTHCARE发盈警 预期2025年度取得股东应占亏损净额约710万港元 同比盈转亏